| Financial Year |
March 31 2023 |
| Monetary Funds |
42,246,382.46 |
| Held-for-trading Financial Assets |
217,874,220.45 |
| Notes Receivable |
87,219,064.50 |
| Accounts Receivable |
177,949,863.32 |
| Advances to Suppliers |
8,860,599.68 |
| Other Receivables |
1,666,252.95 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
102,731.10 |
| Dividend Receivable |
-- |
| Inventories |
158,482,802.55 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,511,832.89 |
| Total Current Assets |
825,606,590.79 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
375,451,253.53 |
| Under-construction Projects |
26,103,479.44 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
40,606,621.75 |
| R&D expenses |
-- |
| Goodwill |
669,644.12 |
| Long-Term Deferred and Prepaid Expenses |
5,700,921.99 |
| Deferred Income Tax Assets |
7,807,968.48 |
| Other Non-Current Assets |
2,145,453.00 |
| Sub-Total of Non-Current Assets |
459,196,731.14 |
| Total Assets |
1,284,803,321.93 |
| Short-Term Loans |
8,868,895.01 |
| Trading Financial liabilities |
-- |
| Notes Payable |
191,673,375.38 |
| Accounts Payable |
54,234,377.21 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
6,245,448.02 |
| Taxes Payable |
4,367,052.10 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
8,559,434.59 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
248,917.54 |
| Other Current Liabilities |
2,783,547.69 |
| Sub-Total of Current Liabilities |
283,113,183.35 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
140,678.30 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
26,997,087.34 |
| Total Liabilities |
310,110,270.69 |
| Paid-In Capital(Or Share Stock) |
178,822,526.00 |
| Capital Surplus |
376,968,418.11 |
| Surplus Reserve |
49,321,335.26 |
| LESS:Treasury Stock |
8,413,200.00 |
| Undistributed Profits |
377,941,406.07 |
| Minority Stockholder's Interest |
52,565.80 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
974,640,485.44 |
| Owner's Equity（Stockholder's Equity） |
974,693,051.24 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,284,803,321.93 |
